The National Cancer Institute awarded $10 million to support research on breast cancer dormancy and relapse biology led by Julio A. Aguirre-Ghiso. The project will investigate the biological processes that drive recurrence after periods where tumors remain clinically undetectable. The grant emphasizes mechanistic drivers rather than symptomatic management, targeting key questions around how cancer cells persist in a dormant state and later resume growth. Dormancy research remains critical for understanding late relapses and for refining interventions that reduce recurrence risk. For sponsors and researchers, the NCI funding highlights continued investment in recurrence prevention and the biological underpinnings of metastasis and persistence.